Form 4 for BCDA BioCardia, Inc.
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-12 · accession 0001437749-22-012953 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-18 | 2022-05-12 | BCDA | GILLIS EDWARD M | SVP, Devices | F - Tax | $1.32 | -12.4K | 23.9K | -34% | -$16.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | F | D | 12,358 | $1.32 | 23,879 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on April 14, 2022 and does not represent a sale by the Reporting Person. |